Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer

Abstract Background Combining antiangiogenic therapy with radioimmunotherapy is believed to further improve antitumor efficacy, but there is still a lack of evidence to support this. This study aimed to investigate the role of the tumor vascular‐targeted agent famitinib with a combination of radioth...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Meng Yuan, Yirui Zhai, Yu Men, Maoyuan Zhao, Xin Sun, Zeliang Ma, Xu Yang, Shuang Sun, Yongxing Bao, Yunsong Liu, Zhouguang Hui
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2022-12-01
Serie:	Thoracic Cancer
Soggetti:	immunotherapy radiotherapy tumor microenvironment vascular‐targeted therapy
Accesso online:	https://doi.org/10.1111/1759-7714.14689
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!